PricingLoginNewsroom
Vol. II — No. 184Remarkable People · Exceptional CompaniesToday's Edition

patient-stratification

(3)
AllCompaniesPeopleStoriesProducts
Company
PhaseV asks the question a failed trial leaves behind: which patients responded?
Ai · Health · Saas

PhaseV asks the question a failed trial leaves behind: which patients responded?

A failed trial can conceal a useful clue. PhaseV uses causal machine learning to look for it, then helps drug developers test a better design before committing patients, time and money.

clinical-trials · causal-aiRead →
Legend
Pilgrim Jackson Is Teaching Cancer Drugs to Find Their People
Founder · Executive · Scientist

Pilgrim Jackson Is Teaching Cancer Drugs to Find Their People

After 13 years inside Celgene, the biochemist left to chase a stubborn question: what if a drug fails because its trial never found the patients whose proteins say yes?

pilgrim-jackson · yatiri-bioRead →
Company
The Biotech Betting That Cancer Drugs Fail Because Nobody Looked at the Proteins
Health · Ai · Enterprise

The Biotech Betting That Cancer Drugs Fail Because Nobody Looked at the Proteins

80% of cancer compounds that reach clinical trials fail. Yatiri Bio thinks the problem is that drug developers have been reading the wrong molecules - and it built a proteomics platform to prove it.

proteomics · mass-spectrometryRead →